Persatuan Kardiologi Hospital Sultanah Bahiyah

29/10/2025

🌉🇺🇸 TCT 2025 – San Francisco, USA
Malaysia di Pentas Dunia! ❤️‍🔥

Kami dengan penuh rasa bangga ingin berkongsi bahawa Hospital Sultanah Bahiyah, Alor Setar sekali lagi telah mengharumkan nama negara di persidangan Transcatheter Cardiovascular Therapeutics (TCT) 2025, iaitu persidangan kardiologi intervensi terbesar di Amerika Syarikat!

✨ Tahniah diucapkan kepada pasukan hebat kami — Mentor Intervensi Kardiologi Dr. Dharmaraj Karthikesan, bekas Fellow Intervensi Kardiologi Dr. Nancy Virginia dan Fellow Intervensi Kardiologi Dr. Christian Sunur — atas kejayaan membentangkan tiga hasil penyelidikan saintifik jabatan kami di pentas antarabangsa yang berprestij ini:

1️⃣ Hasil rawatan pesakit ST-Elevation MI menggunakan drug-coated balloon, strategi hibrid, atau drug-eluting stent
2️⃣ Ultra-low contrast PCI sebagai teknik penjimatan fungsi buah pinggang dalam prosedur kompleks
3️⃣ Revascularisasi kompleks dalam pesakit berisiko tinggi menggunakan strategi bebas logam dengan drug-coated balloon

Walaupun tidak semua ahli pasukan dapat hadir secara fizikal tahun ini, melihat nama “Hospital Sultanah Bahiyah, Alor Setar, Malaysia” terpampang di pembentangan antarabangsa benar-benar membangkitkan rasa bangga dan haru di hati kami. 🇲🇾💖

Kejayaan ini adalah hasil daripada dedikasi, kerjasama dan semangat tinggi seluruh keluarga besar Jabatan Kardiologi — termasuk para doktor, jururawat dan semua kakitangan sokongan — yang sentiasa bekerja tanpa mengenal penat demi kesejahteraan pesakit yang kami rawat setiap hari.

💪 Bersama-sama, kita akan terus berinovasi, berkhidmat, dan melangkah lebih jauh. ❤️

----------------------------------------------------------------------

🌉🇺🇸 TCT 2025 – San Francisco, USA
Representing Malaysia on the Global Stage! ❤️‍🔥

We are proud to share that Hospital Sultanah Bahiyah, Alor Setar has once again made its mark at the Transcatheter Cardiovascular Therapeutics (TCT) 2025, the largest interventional cardiology meeting in the United States!

✨ Our heartfelt congratulations to our brilliant team — Mentor Interventional Cardiologist Dr. Dharmaraj Karthikesan, former Interventional Cardiology Fellow Dr. Nancy Virginia and current Cardiology Fellow Dr. Christian Sunur — for successfully presenting three of our scientific works at this prestigious international platform:

1️⃣ Outcomes in patients with ST-Elevation MI treated with drug-coated balloons, hybrid strategy, or drug-eluting stents
2️⃣ Ultra-low contrast PCI as a renal-sparing technique in complex procedures
3️⃣ Complex revascularisation in high-risk patients using metal-free strategies with drug-coated balloons

Even though not all of us could be there in person, seeing “Hospital Sultanah Bahiyah, Alor Setar, Malaysia” displayed proudly on the international stage fills us with immense pride. 🇲🇾💖

This achievement stands as a testament to the dedication, teamwork, and passion of our entire cardiology family — doctors, nurses, and all supporting staff — who work tirelessly for our patients each day.

💪 Together, we will continue to innovate, heal, and push boundaries — for the hearts that trust us most. ❤️



https://www.facebook.com/share/p/16cVAo9Hby/

30/05/2025

📢 Exciting & Historic News from Persatuan Kardiologi! | Berita Gembira dan Bersejarah daripada Persatuan Kardiologi! 🎓

We are bursting with pride to announce the incredible achievement of our esteemed doctor, Dr. Dharmaraj Karthikesan, a renowned Consultant Interventional Cardiologist! He has just graduated from the prestigious University of Oxford with an MSc in Clinical Trials! 🎉

This is not just a personal triumph, but a landmark moment for Malaysia! Dr. Dharmaraj Karthikesan is the first Malaysian to obtain an MSc in Clinical Trials from the University of Oxford! His dedication and pursuit of excellence are truly inspiring.

Adding to his remarkable list of firsts, Dr. Dharmaraj is also the first Malaysian to receive an ESC (European Society of Cardiology) grant, further solidifying his position as a pioneer in cardiovascular research and development in our nation.

His newly acquired expertise in clinical trials will undoubtedly be invaluable in bringing the latest cutting-edge research and evidence-based practices to patient care in Malaysia, propelling our nation's cardiology landscape forward.

Join us in extending our warmest and most heartfelt congratulations to Dr. Dharmaraj Karthikesan on these truly groundbreaking achievements! We are incredibly proud of his accomplishments and look forward to the significant contributions he will continue to make to cardiology, both nationally and internationally.
--------------------------------------------------------------------------
Kami amat berbangga untuk mengumumkan pencapaian luar biasa doktor kami yang dihormati, Dr. Dharmaraj Karthikesan, seorang Pakar Perunding Kardiologi Intervensi. Beliau baru sahaja menamatkan pengajian dari University of Oxford yang berprestij dengan ijazah MSc dalam Percubaan Klinikal! 🎉

Ini bukan sahaja kejayaan peribadi, tetapi juga detik bersejarah bagi Malaysia! Dr. Dharmaraj Karthikesan adalah rakyat Malaysia pertama yang memperoleh MSc dalam Percubaan Klinikal dari University of Oxford! Dedikasi dan usaha beliau mengejar kecemerlangan sememangnya sangat menginspirasikan.

Menambah lagi kepada senarai pencapaian "pertama" beliau, Dr. Dharmaraj juga merupakan rakyat Malaysia pertama yang menerima geran ESC (European Society of Cardiology), mengukuhkan lagi kedudukan beliau sebagai perintis dalam penyelidikan dan pembangunan kardiovaskular di negara kita.

Kepakaran baharu beliau dalam percubaan klinikal pasti akan menjadi tidak ternilai dalam membawa penyelidikan terkini dan amalan berasaskan bukti kepada penjagaan pesakit di Malaysia, seterusnya memajukan landskap kardiologi negara kita.

Sertai kami dalam meraikan kejayaan Dr. Dharmaraj Karthikesan atas pencapaian yang benar-benar cemerlang ini! Kami amat berbangga dengan pencapaian beliau dan menantikan sumbangan penting yang akan terus beliau berikan kepada bidang kardiologi, di peringkat nasional dan antarabangsa.

05/11/2024

Our second TAVI workshop, being proctored by Dr Gurbhej Singh who came all the way from India to assist our TAVI team in Hospital Sultanah Bahiyah, lead by Saravanan Krishinan , our head of department, Kantha Rao , consultant cardiologist and Dr Tan Chai Yih, fellow cardiologist, We successfully implanted 2 MyVal in 2 extremely high risk aortic stenosis patients who was deemed too frail for open heart surgery. The first case was straight forward implantation with no major complications. The 2nd case was a bit more challenging, from calcified femoral access which required peripheral intra-vascular lithotripsy prior to sending up our devices, and also a Chimney left main stenting post device implantation. To top it , femoral access was too calcified to be secured by vascular closure device and we had our CTC standby Mr Sotheenathan to perform an arterial cut down to secure the bleeding. Both patients were well and planned to be discharged in a day or 2 time. This is a milestone for the department and also a glimpse of hope for the people of Kedah whereby geriatric patients can be offered such procedure whenever needed and indicated.

28/10/2024

Congratulations to Dr Nancy Virginia and Dr Kang Huan Yean who presented our single centre data at TCT (Trancatheter Cardiovascular Therapeutics) 2024 held at Washington DC United States on the usage of drug coated balloons (DCB) in chronic total occlusion (CTO ) and hybrid approach in unprotected left main intervention mentored by Dr Dharmaraj Karthikesan. This approach in intervention may play important role in the future by leaving nothing behind ( metal free implantation).

06/08/2024

04/07/2024

SPIRITUALITY SPARK: WHEN WHAT YOU WORK ON FRUITS

04/07/2024

A great and historic moment for both Cardiology Department of Hospital Sultanah Bahiyah, Alor Star and Hospital Pulau Pinang, successfully collaborated in implanting the latest Aurora Extravascular Implantable Cardioverter Defibrillator (EV ICD) on 4th of July 2024.
The procedure was safely and successfully performed under general anaesthesia by Dr Kantha Rao Narasamuloo (Senior Consultant Cardiologist and Electrophysiologist) together with Dr Saravanan Krishinan (Head of Department & Senior Consultant Electrophysiologist) from Hospital Sultanah Bahiyah Alor Setar under live proctorship from pioneer of EV ICD, Dr Ian Crozier ( Senior Consultant Cardiologist and Electrophysiologist from Chrischurch Hospital New Zealand ).

This EV ICD implantation was the 1st in a public hospital in Malaysia and 2nd in South East Asia, making this event even more memorable. The event was also graced by the presence of Head of Department & Senior Consultant Cardiologist Dato’ Dr Mohamed Jahangir Abdul Wahab during the implantation. A great teamwork with strong support from cardiothoracic team headed by Mr Sotheenathan Krishinan (Senior Consultant Cardiothoracic Surgeon) and anaesthesia team headed by Dr Ang (Senior Consultant Anaesthetist).

This procedure was made possible and tailored for a 50-year-old gentlemen with end-stage renal disease on regular dialysis for 8 years via left brachiocephalic fistula with pre-existing hypertension, dyslipidemia and ischemic dilated cardiomyopathy.

He sustained life threatening ventricular arrhythmia to Hospital Pulau Pinang requiring inpatient implantation of implantable cardiac defibrillator device. The patient also had pre-existing peripheral arterial disease with severely poor vascular access. Despite revascularisation of his coronaries, his cardiac function remained severely poor at 17% which was confirmed by perfusion scan as well. This made him the perfect candidate for an Aurora Extravascular Implantable Cardioverter Defibrillator (EV ICD) in view of his background health history that wasn’t favorable for a transvenous ICD lead.

With the support of Medtronic team Malaysia and United States of America, the HEART team from Hospital Sultanah Bahiyah, Alor Star and Hospital Pulau Pinang were able to carry out this breakthrough event. The patient remained well throughout and post procedure and is expected to be discharged in 1-2 days time. The device had been tested and is capable to fully carried out it’s role of preventing the patient from a fatal arrythmia.

The patient and immediate family members were grateful to all parties involved for providing such up to date and advance treatment in the field of cardiology.

08/05/2024